Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 121 Neoplasms, Plasma Cell 36 Neoplasms 14 Carcinoma, Hepatocellular 13 Recurrence 12 Brain Neoplasms 12 Prostatic Neoplasms 11 Melanoma 11 Central Nervous System Neoplasms 11 Glioblastoma 10 Leukemia 9 Carcinoma, Non-Small-Cell Lung 9 Leukemia, Lymphocytic, Chronic, B-Cell 8 Gliosarcoma 8 Waldenstrom Macroglobulinemia 7 Sarcoma 7 Lung Neoplasms 7 Glioma 7 Colorectal Neoplasms 7 Carcinoma, Renal Cell 7 Liver Neoplasms 6 Myeloproliferative Disorders 5 Myelodysplastic Syndromes 5 Lymphoma, Mantle-Cell 5 Lymphoma, B-Cell, Marginal Zone 5 Lymphoma 5 Kidney Neoplasms 5 Immunoglobulin Light-chain Amyloidosis 5 Myelodysplastic-Myeloproliferative Diseases 4 Lymphoma, Follicular 4

Interventions

Megestrol Acetate 11 Mirtazapine 5 Olanzapine 4 anamorelin 2 Infliximab 2 nabiximols 1 nabilone 1 Watchful Waiting 1 Thalidomide 1 Surveys and Questionnaires 1 Sugars 1 Radiotherapy 1 Quality of Life 1 Palonosetron 1 Observation 1 Nicotine 1 Modafinil 1 Minocycline 1 Melatonin 1 Megestrol 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Flurandrenolone 1 Etanercept 1 Eicosapentaenoic Acid 1 EOM613 1 Dronabinol 1 Docetaxel 1 Dexamethasone 1 Creatine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Anorexia × Thalidomide × Clear all

NCT00379353 2013-02-04

The Effects of Thalidomide on Symptom Clusters

M.D. Anderson Cancer Center

Phase 2 Completed

32 enrolled 14 charts

Anorexia, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon ⚡